Multimodality Imaging-Based Therapeutic Decision in Ischemic Cardiomyopathy and Ventricular Tachycardia – a Case Report
暂无分享,去创建一个
[1] W. Cubała,et al. Commentary concerning treatment of depression in patients with heart failure according to 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2022, European journal of preventive cardiology.
[2] aguda y crónica,et al. Comments on the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2022, Revista espanola de cardiologia.
[3] A. Editorial. Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. , 2022, Revista espanola de cardiologia.
[4] G. Sinagra,et al. [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.
[5] I. V. Van Gelder,et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2021, European heart journal.
[6] J. Chan,et al. Global longitudinal strain as a prognostic marker in cardiac resynchronisation therapy: A systematic review , 2021, International journal of cardiology. Heart & vasculature.
[7] T. Akasaka,et al. Global longitudinal strain evaluated by speckle‐tracking echocardiography as a surrogate marker for predicting replacement fibrosis detected by magnetic resonance‐late gadolinium enhancement in patients with nonischemic cardiomyopathy , 2021, Journal of clinical ultrasound : JCU.
[8] ESC / EAS Guidelines for the Treatment of Dyslipidemias: Lipid Modification to Reduce Cardiovascular Risk , 2020, Digital Doctor.
[9] Jeroen J. Bax,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC) , 2020, Russian Journal of Cardiology.
[10] G. Hindricks,et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. , 2019, Atherosclerosis.
[11] M. Dweck,et al. Myocardial fibrosis: why image, how to image and clinical implications , 2019, Heart.
[12] V. Reddy,et al. Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease: Indications, Strategies, and Outcomes-Part II. , 2017, Journal of the American College of Cardiology.
[13] S. Saito,et al. A unique complication of the retrograde approach in angioplasty for chronic total occlusion of the coronary artery , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[14] James A. White,et al. Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. , 2017, JACC. Heart failure.